Paragon Financial Statements From 2010 to 2025
| PXS Stock | EUR 0.29 0.00 0.00% |
Check Paragon Care financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Paragon Care's main balance sheet or income statement drivers, such as , as well as many indicators such as . Paragon financial statements analysis is a perfect complement when working with Paragon Care Valuation or Volatility modules.
Paragon |
Paragon Care Limited Company Return On Equity Analysis
Paragon Care's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Paragon Care Return On Equity | 0.0449 |
Most of Paragon Care's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Paragon Care Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Paragon Care Limited has a Return On Equity of 0.0449. This is 100.19% lower than that of the Healthcare sector and 99.4% lower than that of the Medical Distribution industry. The return on equity for all Germany stocks is 114.48% lower than that of the firm.
Paragon Care Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Paragon Care's current stock value. Our valuation model uses many indicators to compare Paragon Care value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Paragon Care competition to find correlations between indicators driving Paragon Care's intrinsic value. More Info.Paragon Care Limited is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Paragon Care Limited is roughly 1.77 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Paragon Care's earnings, one of the primary drivers of an investment's value.About Paragon Care Financial Statements
Paragon Care stakeholders use historical fundamental indicators, such as Paragon Care's revenue or net income, to determine how well the company is positioned to perform in the future. Although Paragon Care investors may analyze each financial statement separately, they are all interrelated. For example, changes in Paragon Care's assets and liabilities are reflected in the revenues and expenses on Paragon Care's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Paragon Care Limited. Please read more on our technical analysis and fundamental analysis pages.
Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia and New Zealand. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. PARAGON CARE operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 508 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Paragon Stock
Paragon Care financial ratios help investors to determine whether Paragon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Paragon with respect to the benefits of owning Paragon Care security.